Akihiro Seki
- Hepatology top 5%
- Liver physiology and pathology 7
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Genetics top 10%
- Mesenchymal stem cell research 5
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 6
- Colorectal Cancer Treatments and Studies 4
- Lung Cancer Research Studies 4
-
- Lung Cancer Treatments and Mutations 8
-
- Liver Disease Diagnosis and Treatment 8
- Co-authors
- Yoshio SakaiMasao HondaTakashi WadaShuichi KanekoTakuya KomuraAlessandro NastiTatsuya YamashitaMasayuki Takamura
- Cited by
- HepatologyGeneticsOncology
- Partner nations
- JapanUnited StatesBelgium
In The Last Decade
Akihiro Seki
35 papers receiving 788 citations
Peers
Comparison fields: 5 of 89
- Hepatology 158
- Genetics 131
- Oncology 250
- Pulmonary and Respiratory Medicine 206
- Epidemiology 155
Countries citing papers authored by Akihiro Seki
This map shows the geographic impact of Akihiro Seki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Seki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Seki more than expected).
Fields of papers citing papers by Akihiro Seki
This network shows the impact of papers produced by Akihiro Seki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Seki. The network helps show where Akihiro Seki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Akihiro Seki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 1 | |
| 9 | 2021 | 11 | |
| 10 | 2021 | 41 | |
| 11 | 2020 | 86 | |
| 12 | 2019 | 106 | |
| 13 | 2018 | 1 | |
| 14 | 2017 | 45 | |
| 15 | 2017 | 44 | |
| 16 | 2014 | 29 | |
| 17 | 2014 | 1 | |
| 18 | 2013 | 100 | |
| 19 | 2011 | 1 | |
| 20 | 2004 | 41 |
About Akihiro Seki
Akihiro Seki is a scholar working on Hepatology, Oncology and Genetics, having authored 41 papers that have together received 801 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Liver Disease Diagnosis and Treatment (8 papers), Liver physiology and pathology (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Pancreatic and Hepatic Oncology Research (6 papers), Mesenchymal stem cell research (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Hepatology (158 citations), Genetics (131 citations) and Oncology (250 citations). Akihiro Seki has collaborated with scholars based in Japan, United States and Belgium. Frequent co-authors include Yoshio Sakai, Masao Honda, Takashi Wada, Shuichi Kaneko, Takuya Komura, Alessandro Nasti, Tatsuya Yamashita, Masayuki Takamura, Eishiro Mizukoshi and Taro Yamashita. Their work appears in journals such as Journal of Clinical Oncology, Hepatology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.